← Leaderboards
Ake P Elhammer
Aureogen Biosciences, Inc.
$3,891,026
Attributed
$3,891,026
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2006–12$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,891,026 · 5
By mechanism
R44$2,460,182 · 1
R43$1,430,844 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cyclic Peptides”
- David Heimbrook · Leidos Biomedical Research, Inc.$82,615,334
- M. Reza Ghadiri · Scripps Research Institute$16,415,739
- Steven J Brown · Scripps Research Institute, The$13,788,882
- John C Burnett · Mayo Clinic Coll Of Medicine, Rochester$13,400,656
- Kenneth E Palmer · Large Scale Biology Corporation$12,588,258
- Larry Arthur$10,605,000
Research focus
Cyclic PeptidesAmino AcidsOrganismPharmaceutical PreparationsPropertyMarketingGenesIn VitroPeptide SynthaseComplexPeptidesModificationPreparationProductionPositioning AttributeBiological FactorsGenerationsGeneticCostFungusGenetic EngineeringAntifungal AgentsEngineeringSynthesis Chemistry
Grant awards (10)
Novel Antifungals by Engineering the AbA NRPS gene$240,904
R44 · FY2012 · AI · contact PI
Novel Antifungals by Engineering the AbA NRPS gene$240,577
R44 · FY2011 · AI · contact PI
Generation of novel HCV drugs through engineereing of the cssA gene$300,000
R43 · FY2009 · AI · contact PI
Novel Antifungals by Engineering the AbA NRPS gene$682,676
R44 · FY2008 · AI · contact PI
Generation of novel HCV drugs through engineereing of the cssA gene$300,000
R43 · FY2008 · AI · contact PI
Generation of novel drugs against drug resistant bacteria through engineering of$286,746
R43 · FY2008 · AI · contact PI
Novel Antifungals by Engineering the AbA NRPS gene$658,406
R44 · FY2007 · AI · contact PI
A Bacitracin derivative for systemic use$381,116
R43 · FY2007 · AI · contact PI
Novel Antifungals by Engineering the AbA NRPS gene$637,619
R44 · FY2006 · AI · contact PI
Novel Antifungals by Engineering the AbA NRPS gene$162,982
R43 · FY2004 · AI